Search clinical trials for: extended-release exenatide
Total 6554 results
-
Sun Yat-sen UniversityWithdrawnRenal Function DisorderChina
-
PfizerCompletedPainUnited States, Puerto Rico
-
AbbVie (prior sponsor, Abbott)Completed
-
Roy D. Bloom, MDVeloxis PharmaceuticalsRecruitingKidney Transplant; ComplicationsUnited States
-
Christine M. Kleinert Institute for Hand and MicrosurgeryUnknownMedian Nerve CompressionUnited States
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...RecruitingKnee Osteoarthritis | MetforminBangladesh
-
University of Alabama at BirminghamCompletedRenal Transplant InfectionUnited States
-
Associazione Qol-oneCompletedAcute Myeloid LeukemiaItaly
-
Indivior Inc.CompletedOpioid Use Disorder, Moderate | Opioid Use Disorder, SevereUnited States
-
AstraZenecaCompletedComparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal InsulinsType 2 DiabetesUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusItaly, Korea, Republic of, Hungary, Canada, Australia
-
Dexa Medica GroupCompletedMetformin XR BE Study in Healthy Volunteers With Single and Multiple DoseIndonesia
-
Abbott Medical DevicesCompletedPeripheral Artery DiseaseUnited States
-
Huazhong University of Science and TechnologyCompletedType 2 Diabetes MellitusChina
-
AstraZenecaEli Lilly and CompanyCompleted
-
Overseas Pharmaceuticals, Ltd.Beijing Capton Pharmaceutical Technology Development Co., LTDNot yet recruiting
-
Oklahoma Medical Research FoundationUniversity of Wisconsin, Madison; University of Oklahoma; National Institute...RecruitingInsulin Resistance | Chronic Disease | Aging | Insulin Sensitivity | MitochondriaUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedPancreatic CancerUnited States
-
Astellas Pharma IncCompletedMajor Depressive DisorderJapan
-
Johnson & Johnson Consumer and Personal Products...Completed
-
AstraZenecaWithdrawn
-
Intarcia TherapeuticsTerminatedType 2 DiabetesUnited States
-
AstraZenecaCompletedType 2 DiabetesUnited States
-
University of Alabama at BirminghamAmylin Pharmaceuticals, LLC.TerminatedType 2 Diabetes Mellitus | Bone RemodelingUnited States
-
Hawler Medical UniversityCompleted
-
Brigham and Women's HospitalHarvard Medical School (HMS and HSDM); Patient-Centered Outcomes Research InstituteEnrolling by invitation
-
Johan NormarkUmeå University; Värmland County Council, Sweden; Örebro University, Sweden; Region... and other collaboratorsActive, not recruiting
-
Alexandria UniversityCompleted
-
Lene V. Ravn-NielsenUniversity of Southern Denmark; The Hospitals Pharmacies' and Amgros' Research... and other collaboratorsCompleted
-
West China HospitalRoyal Liverpool University HospitalUnknownCarcinoma, Pancreatic DuctalChina
-
Endo PharmaceuticalsCompleted
-
Endo PharmaceuticalsCompletedChronic PainUnited States
-
New York State Psychiatric InstituteCompletedOpioid-use DisorderUnited States
-
Poitiers University HospitalChiesi Farmaceutici S.p.A.TerminatedImmunosuppression | Kidney TransplantFrance
-
GlaxoSmithKlineCompletedRestless Legs SyndromeUnited States, Canada
-
AIO-Studien-gGmbHMerck Sharp & Dohme LLC; Janssen-Cilag G.m.b.H; Daiichi Sankyo Europe, GmbH,...RecruitingAdvanced Solid TumorGermany
-
Oxford University Hospitals NHS TrustWithdrawn
-
Beijing Chao Yang HospitalCompleted
-
Kyunghee University Medical CenterCompleted
-
Amsterdam UMC, location VUmcUnknownPatients With a First Acute Myocardial Infarction to be Treated With Primary Percutaneous Coronary Intervention (PCI).Netherlands
-
St Helens & Knowsley Teaching Hospitals NHS TrustWithdrawn
-
Javeriana UniversityHospital Universitario San Ignacio; Fundación Santa Fe de Bogota; Fundación Cardioinfantil...CompletedProstatic Neoplasms | Secondary Malignant Neoplasm of Lymph NodeColombia
-
Dawnrays Pharmaceutical (Holdings) LimitedUnknown
-
GlaxoSmithKlineCompletedRestless Legs Syndrome | Restless Legs Syndrome (RLS)Spain, United States, Belgium, Sweden, Australia, Netherlands, United Kingdom, Italy, Austria, Germany, Denmark, France, Norway
-
Yale UniversityCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Austria, Canada, Italy, Netherlands, Spain, United Kingdom, Taiwan, Thailand, Bulgaria, Belgium, Germany, Korea, Republic of, Hungary, Philippines, China, Malaysia, Hong Kong, New Zealand, Argentina, Czechia, Slovakia, Braz... and more
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States